Christopher G. Smith

1.2k total citations · 1 hit paper
15 papers, 811 citations indexed

About

Christopher G. Smith is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Christopher G. Smith has authored 15 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Obstetrics and Gynecology and 5 papers in Reproductive Medicine. Recurrent topics in Christopher G. Smith's work include Colorectal Cancer Treatments and Studies (5 papers), Uterine Myomas and Treatments (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Christopher G. Smith is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Uterine Myomas and Treatments (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Christopher G. Smith collaborates with scholars based in United States, United Kingdom and Netherlands. Christopher G. Smith's co-authors include Jeremy P. Cheadle, Tim Maughan, David J. Fisher, Susan D. Richman, Michel Seymour, Philip Quirke, Richard Kaplan, Anton F. J. de Haan, Bauke Ylstra and Sabine Venderbosch and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Christopher G. Smith

15 papers receiving 801 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies

2014 534 citations Sabine Venderbosch, Irıs D. Nagtegaal et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Christopher G. Smith

Since Specialization

Citations

This map shows the geographic impact of Christopher G. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher G. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher G. Smith more than expected).

Fields of papers citing papers by Christopher G. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher G. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher G. Smith. The network helps show where Christopher G. Smith may publish in the future.

Co-authorship network of co-authors of Christopher G. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher G. Smith. A scholar is included among the top collaborators of Christopher G. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher G. Smith. Christopher G. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	The Log Odds of Positive Lymph Nodes Predict Survival of Advanced-Stage Endometrial Cancer: A Retrospective Analysis of 3230 Patients in the Surveillance, Epidemiology, and End Results Database 2022 ·Journal of Gynecologic Surgery ·Christopher G. Smith, Quan Chen, Bin Huang, Rachel W. Miller, Christopher P. DeSimone, Charles S. Dietrich, Frederick R. Ueland, Holly H. Gallion, Edward J. Pavlik, John R. van Nagell, (unknown)	1
2	Invasive Hidradenocarcinoma of the Vulva: A Case Report and Literature Review 2020 ·Journal of Gynecologic Surgery ·Christopher G. Smith, Christopher P. DeSimone	2
3	Transvaginal Ultrasound Can Accurately Predict the American Society of Reproductive Medicine Stage of Endometriosis Assigned at Laparoscopy 2020 ·Journal of Minimally Invasive Gynecology ·Mathew Leonardi, Mercedes Espada, (unknown), Danny Chou, (unknown), Christopher G. Smith, (unknown), G. Condous	39
4	Reloadable Stapler Use during Peripartum Hysterectomy for Placenta Accreta Spectrum: A Novel Surgical Technique and Case Series 2020 ·American Journal of Perinatology ·Christopher G. Smith, Hope M. Cottrill, John R. Barton	3
5	Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers—Stage Challenges Categorical Assignments of Indolence & Aggressiveness 2020 ·Diagnostics ·Edward J. Pavlik, Christopher G. Smith, (unknown), Elizabeth Harvey, Bin Huang, Quan Chen, (unknown), Brian Burgess, (unknown), J Górski, Lauren Baldwin, Rachel W. Miller, Christopher P. DeSimone, Charles S. Dietrich, Holly H. Gallion, Frederick R. Ueland, John R. van Nagell	15
6	Characteristics Associated with Prolonged Length of Stay after Myomectomy for Uterine Myomas 2019 ·Journal of Minimally Invasive Gynecology ·Christopher G. Smith, Daniel L. Davenport, (unknown)	6
7	Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery 2019 ·Healthcare ·Christopher G. Smith, Daniel L. Davenport, J Górski, (unknown), Brian Burgess, (unknown), Lauren Baldwin, Rachel W. Miller, Christopher P. DeSimone, Charles S. Dietrich, Holly H. Gallion, Edward J. Pavlik, John R. van Nagell, Frederick R. Ueland	11
8	Progression and recurrence patterns of vulvar intraepithelial neoplasia 2018 ·Gynecologic Oncology ·(unknown), Donglin Yan, (unknown), Christopher G. Smith, (unknown), (unknown), Lauren Baldwin, (unknown), Frederick R. Ueland, Edward J. Pavlik, Rachel W. Miller	1
9	BRAF and NRAS Locus-Specific Variants Have Different Outcomes on Survival to Colorectal Cancer 2016 ·Clinical Cancer Research ·(unknown), Christopher G. Smith, Tim Maughan, Richard Kaplan, Valentina Escott‐Price, Jeremy P. Cheadle	35
10	Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials 2016 ·Annals of Oncology ·Jenny F. Seligmann, David J. Fisher, Christopher G. Smith, Susan D. Richman, Faye Elliott, Sarah Brown, Richard Adams, Tim Maughan, Philip Quirke, Jeremy P. Cheadle, Michel Seymour, Gary Middleton	124
11	Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival 2015 ·Clinical Cancer Research ·Christopher G. Smith, David J. Fisher, Rebecca Harris, Tim Maughan, Amanda I. Phipps, Susan D. Richman, Michel Seymour, Ian Tomlinson, Dan Rosmarin, David Kerr, Andrew T. Chan, Ulrike Peters, Polly A. Newcomb, Shelley Idziaszczyk, Hannah D. West, Angela Meade, Richard Kaplan, Jeremy P. Cheadle	16
12	Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies breakdown → 2014 ·Clinical Cancer Research ·Sabine Venderbosch, Irıs D. Nagtegaal, Tim Maughan, Christopher G. Smith, Jeremy P. Cheadle, David J. Fisher, Richard Kaplan, Philip Quirke, Michel Seymour, Susan D. Richman, Gerrit A. Meijer, Bauke Ylstra, Daniëlle A.M. Heideman, Anton F. J. de Haan, Cornelis J.A. Punt, Miriam Koopman	534
13	Epiregulin (EREG) and amphiregulin (AREG) gene expression to predict response to cetuximab therapy in combination with oxaliplatin (Ox) and 5FU in first-line treatment of advanced colorectal cancer (aCRC). 2012 ·Journal of Clinical Oncology ·Richard Adams, David J. Fisher, Susan Farragher, Alastair Scott, Christopher G. Smith, Michelle D. James, Jeremy P. Cheadle, Laura Nichols, Angela Meade, Richard Kaplan, Richard H. Wilson, Harpreet Wasan, Tim Maughan	5
14	Use of epiregulin (EREG) and amphiregulin (AREG) gene expression to predict response to cetuximab (cet) in combination with oxaliplatin (Ox) and 5FU in the first-line treatment of advanced colorectal cancer (aCRC). 2012 ·Journal of Clinical Oncology ·Richard Adams, David J. Fisher, Susan Farragher, Bharat Jasani, Christopher G. Smith, Michelle D. James, Jeremy P. Cheadle, Laura Nichols, Angela Meade, Richard Kaplan, Richard H. Wilson, Harpreet Wasan, Tim Maughan	18
15	Outpatient Vaginal Hysterectomy: A Pilot Project 2000 ·Journal SOGC ·(unknown), (unknown), Christopher G. Smith	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact